Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Central Veins in Brain Lesions Visualized With High-Field Magnetic Resonance Imaging: A Pathologically Specific Diagnostic Biomarker for Inflammatory Demyelination in the Brain.
Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis.
A history of multiple sclerosis investigations in Canada between 1850 and 1950.
Fatigue and sleep disturbance in multiple sclerosis.
Oxygen cost of walking in persons with multiple sclerosis: disability matters, but why?
2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro.
Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice.
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.
Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation.
Trigeminal neuralgia: New classification and diagnostic grading for practice and research.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier.
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes.
Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects.
Impaired adult myelination in the prefrontal cortex of socially isolated mice.
Treatment of multiple sclerosis in children and its challenges.
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
Dynamic change in magnetic resonance imaging of patients with neuromyelitis optica.
[Applications of Optical Coherence Tomography (OCT) in Neuro-ophthalmology.]
Treatment of pediatric multiple sclerosis.
Quality of life reporting in multiple sclerosis clinical trials: enough quality?
Disability in multiple sclerosis: A reference for patients and clinicians.
Sexual disparities in the incidence and course of MS.
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Pages
« first
‹ previous
…
345
346
347
348
349
350
351
352
353
…
next ›
last »